Neda Rasouli MD
Diabetes, Lipid Metabolism
Professor, Medicine and Pharmacy, University of Colorado School of Medicine
Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Dr. Rasouli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Neda Rasouli is an endocrinologist located in Aurora, CO, with subspecialties in diabetes and lipid metabolism. She completed her fellowship in endocrinology, diabetes, and metabolism at the University of Arkansas for Medical Sciences College of Medicine. Her clinical expertise includes diabetes mellitus, obesity and related disorders, lipid metabolism disorders, insulin resistance, and metabolic syndrome. Dr. Rasouli has published extensively in reputable journals, with notable works on glucose-lowering medications and glycemic outcomes in type 2 diabetes. She has participated in various clinical trials, such as studies on tirzepatide, volanesorsen, and vitamin D related to diabetes management. She has received honors including CMS Meaningful Use Stage 1 Certification and recognition as a Most Compassionate Doctor.
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
- Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1997 - 2000
- Tehran University of Medical Sciences School of MedicineClass of 1995
Certifications & Licensure
- CO State Medical License 2009 - 2025
- AR State Medical License 2000 - 2010
- MI State Medical License 2000 - 2001
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Most Compassionate Doctor American Registry
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Compar...Kristina M Utzschneider, Mark Tripputi, Nicole M Butera, Andrea Mari, Samuel P Rosin
Diabetes Care. 2025-04-01 - Tirzepatide for Older Adults with Type 2 Diabetes and Without Obesity: A Post Hoc Analysis of the SURPASS Clinical Trials.Neda Rasouli, John P H Wilding, Anita Y M Kwan, Jim S Paik, Palash Sharma
Diabetes Therapy. 2025-04-01 - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-contr...Marc P Bonaca, Andrei-Mircea Catarig, Kim Houlind, Bernhard Ludvik, Joakim Nordanstig
Lancet. 2025-03-28
Journal Articles
- Glycaemic Efficacy and Safety of Linagliptin Compared to Basal‐Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non‐Cardiac Surgery: A Multicenter Ran...Neda Rasouli, MD, Diabetes, Obesity and Metabolism
Press Mentions
- The New Penicillin? Pharmacotherapy for ObesityNovember 19th, 2024
- Given Shortages, Who ‘Deserves’ Ozempic and GLP-1 Drugs?August 10th, 2024
- Research Helps Show Which Type 2 Diabetes Medication May Work BestJuly 23rd, 2024
- Join now to see all
Grant Support
- Effects Of Insulin Sensitizers And PPAR Ligands On Lipotoxicity In Subjects WithNational Center For Research Resources2006
- Effects Of Insulin Sensitizers On Glucose And Fat Metabolism In Subjects With GENational Center For Research Resources2005–2006
- Effects Of Insulin Sensitizers Of Beta Cell Function And LipotoxicityNational Center For Research Resources2005–2006
- Pathophysiology Of Atypical Diabetes In African Americans: A Pilot ProposalNational Center For Research Resources2004
- Insulin Sensitizers Of Beta Cell Function &LipotoxicityNational Center For Research Resources2004
Committees
- member, Standards of Medical Care in Diabetes - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
